Bayer

Not intended for U.S. and UK Media (IN BRIEF) Bayer AG has partnered with Acuitas Therapeutics, Inc. to enhance its gene therapy portfolio. Acuitas’ lipid nanoparticle (LNP) delivery technology will enable targeted and efficient delivery of gene editing RNA components … Read the full press release →

Not intended UK Media (IN BRIEF) Bayer and Cedilla Therapeutics have entered into an exclusive license agreement to develop and commercialize Cedilla’s CyclinE1/CDK2 complex inhibitors for precision oncology. These inhibitors target oncogenic drivers and offer a unique method of action, … Read the full press release →

(IN BRIEF) Bayer has announced the recipients of its 2023 Grants4Ag program, which will provide funding and mentorship to researchers working on sustainability and biotechnology in agriculture. The program will award grants ranging from €5,000 to €15,000 and connect researchers … Read the full press release →

(NOTIZIA IN BREVE) Bayer, la società di scienze della vita, ha annunciato un investimento di 60 milioni di euro nel suo impianto di produzione di semi di mais a Pochuiky, in Ucraina, per rafforzare la sua attività di Crop Science … Read the full press release →

(IN BRIEF) Bayer, the life sciences company, has announced a €60 million investment in its corn seed production facility in Pochuiky, Ukraine, to strengthen its Crop Science business and contribute to rebuilding the economy of the country. The investment includes … Read the full press release →

(IN BRIEF) Siemens has supplied Bayer’s Crop Science Division with pressure transmitters containing standardized ID links, enabling the transfer of digital documentation in real time to the ERP system used by the customer. The transmitters feature technology that complies with … Read the full press release →

(IN BRIEF) Bayer has launched a new water strategy at the UN 2023 Water Conference in New York, which aims to make water an integral part of its business decisions, investments, and supplier selection. The strategy reflects the company’s role … Read the full press release →

(NOTICIA EN BREVE) Bayer y la empresa francesa M2i Group se unen para ofrecer soluciones de protección de cultivos basadas en feromonas a los productores de frutas y verduras de todo el mundo. Bayer se convertirá en distribuidor exclusivo de … Read the full press release →

(IN BRIEF) Bayer and French firm M2i Group team up to offer pheromone-based crop protection solutions to fruit and veggie growers globally. Bayer to become exclusive distributor of select M2i products aimed at Lepidoptera pests in crops such as tomatoes, … Read the full press release →

Non destinato ai media statunitensi e britannici (NOTIZIA IN BREVE) Il comitato per i medicinali per uso umano dell’Agenzia europea per i medicinali ha raccomandato l’autorizzazione all’immissione in commercio nell’Unione europea di darolutamide, un inibitore orale del recettore degli androgeni, … Read the full press release →

Not intended for U.S. and UK Media (IN BRIEF) The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended darolutamide, an oral androgen receptor inhibitor, for marketing authorization in the European Union as a treatment for patients … Read the full press release →

(PRESS RELEASE) SAN SEBASTIAN, Spain, 9-Jan-2023 — /EuropaWire/ — Bayer (ETR: BAYN), a global enterprise with core competencies in the life science fields of healthcare and nutrition and and one of the largest pharmaceutical companies in the world, has announced … Read the full press release →

(COMUNICADO DE PRENSA) SAN SEBASTIAN, Spain, 9-Jan-2023 — /EuropaWire/ — Bayer (ETR: BAYN), una empresa global con competencias básicas en los campos de las ciencias biológicas de la salud y la nutrición y una de las compañías farmacéuticas más grandes … Read the full press release →